| Followers | 57 |
| Posts | 7298 |
| Boards Moderated | 0 |
| Alias Born | 05/06/2014 |
Saturday, August 05, 2023 6:01:13 AM
08/05/23 - 1,121,070,972
07/25/23 - 1,117,986,655
07/21/23 - 1,117,882,694
07/16/23 - 1,117,782,749
07/13/23 - 1,115,581,954
07/12/23 - 1,115,457,429
06/29/23 - 1,103,777,305
06/28/23 - 1,100,777,305
06/24/23 - 1,100,749,003
06/23/23 - 1,099,476,360
06/19/23 - 1,099,449,648
06/16/23 - 1,090,407,632
06/13/23 - 1,090,059,940
05/31/23 - 1,090,028,440
05/20/23 - 1,087,044,376
05/05/23 - 1,086,771,876
04/25/23 - 1,084,219,813
04/20/23 - 1,084,190,793
04/19/23 - 1,083,383,101
04/12/23 - 1,082,502,689
04/11/23 - 1,082,262,689
04/07/22 - 1,082,184,564
04/04/23 - 1,082,174,564
04/01/23 - 1,081,609,033
03/31/23 - 1,081,530,908
03/29/23 - 1,081,359,732
03/18/23 - 1,081,203,482
03/16/23 - 1,081,016,689
03/14/23 - 1,077,225,729
03/10/23 - 1,075,575,729
03/09/23 - 1,074,891,254
03/06/23 - 1,073,244,158
02/28/23 - 1,072,879,079
02/25/23 - 1,072,806,892
02/22/23 - 1,072,776,892
02/11/23 - 1,072,626,892
02/08/23 - 1,069,174,830
01/27/23 - 1,069,071,705
01/24/23 - 1,066,721,705
01/21/23 - 1,066,654,924
01/14/23 - 1,061,131,115
01/06/23 - 1,061,044,165
2022:
12/21/22 - 1,058,132,006
01/22/22 - 949,180,606
2022 Detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170751056;
2021:
12/31/21 - 947,621,531
01/12/21 - 822,825,147
2020:
12/31/20 - 822,716,397
01/27/20 - 625,187,160
2020-2021 Detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167328119;
Shares outstanding from
https://www.otcmarkets.com/stock/NWBO/quote
07/25/23 - 1,117,986,655
07/21/23 - 1,117,882,694
07/16/23 - 1,117,782,749
07/13/23 - 1,115,581,954
07/12/23 - 1,115,457,429
06/29/23 - 1,103,777,305
06/28/23 - 1,100,777,305
06/24/23 - 1,100,749,003
06/23/23 - 1,099,476,360
06/19/23 - 1,099,449,648
06/16/23 - 1,090,407,632
06/13/23 - 1,090,059,940
05/31/23 - 1,090,028,440
05/20/23 - 1,087,044,376
05/05/23 - 1,086,771,876
04/25/23 - 1,084,219,813
04/20/23 - 1,084,190,793
04/19/23 - 1,083,383,101
04/12/23 - 1,082,502,689
04/11/23 - 1,082,262,689
04/07/22 - 1,082,184,564
04/04/23 - 1,082,174,564
04/01/23 - 1,081,609,033
03/31/23 - 1,081,530,908
03/29/23 - 1,081,359,732
03/18/23 - 1,081,203,482
03/16/23 - 1,081,016,689
03/14/23 - 1,077,225,729
03/10/23 - 1,075,575,729
03/09/23 - 1,074,891,254
03/06/23 - 1,073,244,158
02/28/23 - 1,072,879,079
02/25/23 - 1,072,806,892
02/22/23 - 1,072,776,892
02/11/23 - 1,072,626,892
02/08/23 - 1,069,174,830
01/27/23 - 1,069,071,705
01/24/23 - 1,066,721,705
01/21/23 - 1,066,654,924
01/14/23 - 1,061,131,115
01/06/23 - 1,061,044,165
2022:
12/21/22 - 1,058,132,006
01/22/22 - 949,180,606
2022 Detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170751056;
2021:
12/31/21 - 947,621,531
01/12/21 - 822,825,147
2020:
12/31/20 - 822,716,397
01/27/20 - 625,187,160
2020-2021 Detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167328119;
Shares outstanding from
https://www.otcmarkets.com/stock/NWBO/quote
Bullish
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
